ArgenTag have joined PacBio’s Compatible Partner Program and opened a grant to provide access to single-cell sequencing tech.
Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results